Non-venereal sclerosing lymphangitis of the penis: A report of two cases
Journal Title: Türkderm - Deri Hastalıkları ve Frengi Arşivi - Year 2017, Vol 51, Issue 3
Abstract
Non-venereal sclerosing lymphangitis (NVSL) is a rare disease that develops after vigorous sexual intercourse. The disease was first described in 1923 by Hoffman. The condition is observed usually in the second or third decade of life. NVSL is characterized by a rope-like hard swelling around the coronal sulcus of the penis. It is generally painless and benign and usually resolves spontaneously. Penile Mondor’s disease (PMD) must be considered in differential diagnosis. The lesion is harder and adherent to the underlying skin in PMD. Patients often have pain. Venous Doppler ultrasound is normal in NVSL but increased echogenicity and incompressible veins are observed in PMD. Here, we report two cases of NVSL. Establishing the diagnosis and knowing the course of the disease by dermatologists and urologists is very important to avoid misdiagnosis, unnecessary laboratory examinations and treatment.
Authors and Affiliations
Ersoy Acer, Mustafa Karabıçak
Successful treatment of confluent and reticulated papillomatosis with tetracycline and mupirocin
Confluent and reticulated papillomatosis characterized by hyperkeratotic-pigmented papules is a rare dermatosis, which tends to settle in seborrheic areas. Some cutaneous disorders share the same features. Herein, we rep...
Evaluation of the use of complementary and alternative therapy in patients with psoriasis and acne vulgaris
Background and Design: The aim of this study was to explore the use of complementary and alternative medicine (CAM) therapy in patients with acne vulgaris (AV) and psoriasis and their attitudes towards CAM. Materials an...
The role of uric acid in metabolic syndrome in patients with psoriasis
Background and Design: Psoriasis patients have increased risk of obesity, metabolic syndrome and cardiovascular disease. Uric acid is a metabolic marker associated with metabolic syndrome and cardiovascular diseases. Uri...
May dermal fillers be an effective application in correcting lip asymmetries?
.
Ustekinumab associated bullous pemphigoid in a psoriasis patient and a review of the literature
Ustekinumab is a Food and Drug Administration-approved (2009) novel treatment for psoriasis patients. This anti-interleukin-12/23p40 monoclonal antibody is effective in the treatment of plaque psoriasis and psoriatic art...